FINCH THERAPEUTICS GROUP

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch FNCH and buy or sell other stocks, ETFs, and their options commission-free!

About FNCH

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. 

CEO
Matthew P. Blischak
CEOMatthew P. Blischak
Employees
18
Employees18
Headquarters
Somerville, Massachusetts
HeadquartersSomerville, Massachusetts
Founded
2014
Founded2014
Employees
18
Employees18

FNCH Key Statistics

Market cap
601.81M
Market cap601.81M
Price-Earnings ratio
-2.53
Price-Earnings ratio-2.53
Dividend yield
—
Dividend yield—
Average volume
107.56K
Average volume107.56K
High today
$12.50
High today$12.50
Low today
$12.45
Low today$12.45
Open price
$12.45
Open price$12.45
Volume
1.38K
Volume1.38K
52 Week high
$12.50
52 Week high$12.50
52 Week low
$0.2505
52 Week low$0.2505

People also own

Based on the portfolios of people who own FNCH. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Ocugen, Inc
Lucid Group
Ideanomics
Cenntro Inc.
Tilray Brands
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.